HOME >> MEDICINE >> NEWS
Hopkins study shows low-dose aspirin suppresses clumping of blood platelets in both sexes

A once-daily pill of low-dose aspirin helps lower the potential for clot-forming blood cells - in both men and women - to stick together in narrow blood vessels, a study from Johns Hopkins shows.

In what is believed to be the first direct comparison of blood cell testing in both sexes of 81 milligrams of acetyl salicylic acid a day, Hopkins researchers found aspirin therapy prevents the clumping together of these clot-forming cells, called platelets. Clots in blood vessels of the heart and brain can cause heart attacks and strokes.

However, while the drug's overall effects on blood cell function were the same for men and women, the investigators found that women's platelets reacted somewhat more strongly to aspirin before the start of therapy, and remained so even after treatment.

The study findings appear in the Journal of the American Medical Association online March 21, and challenge the conclusions from several other recent studies, including the federal Women's Health Study, which showed low-dose aspirin had no effect in preventing heart attacks in women, even though it worked in men. Previous results, the researchers say, were not likely caused by the failure of aspirin to prevent platelets from clumping together and forming blood clots in women.

"Women are clearly benefiting from taking aspirin and should continue to take it to improve their cardiovascular health," says study senior investigator Diane Becker, M.P.H., Sc.D., a professor at The Johns Hopkins University School of Medicine and Bloomberg School of Public Health. "Aspirin has been proven by all previous studies to lower the risk of stroke and, as our latest findings show, it also reduces platelet aggregation that can lead to potentially fatal clots in blood vessels."

"Our results show that aspirin does what it is supposed to do in both men and women," says platelet biologist and study co-author Nauder Faraday, M.D., an associate professor at Hopkins. "
'"/>

Contact: David March
dmarch1@jhmi.edu
410-955-1534
Johns Hopkins Medical Institutions
21-Mar-2006


Page: 1 2 3 4

Related medicine news :

1. Johns Hopkins begins aggressive screening for superbugs in children
2. Johns Hopkins develops pancreas cancer risk model
3. Hopkins study reveals white blood cells can both hurt and help transplanted kidneys
4. Hopkins scientists link immune response to ghost parasites and severely congested sinuses
5. Hopkins-led study finds that chronic form of depression runs in families
6. Diagnosis and referrals for kidney disease fall well short of need, Johns Hopkins study shows
7. Johns Hopkins Childrens Center to lead largest-ever study on kidney disease in children
8. Hopkins scientists show hallucinogen in mushrooms creates universal mystical experience
9. Johns Hopkins lab scientists tame overactive CF protein
10. Hopkins researchers develop new quick tool to sort out insect bites in children
11. Hopkins scientists use embryonic stem cells, new cues to awaken latent motor nerve repair

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/14/2019)... ... November 14, 2019 , ... With Giving Tuesday on Dec. ... businesses and organizations about the benefits of supporting local hospitalized veterans throughout Maryland. ... millions of people to give, collaborate and celebrate generosity before the holidays, and ...
(Date:11/14/2019)... ... , ... EMulate Therapeutics, Inc., a clinical-stage therapeutic device company ... 5 poster presentations related to its medical devices for treating adult and pediatric ... Phoenix, beginning on November 20 . , Two posters will be ...
(Date:11/14/2019)... ... November 14, 2019 , ... ... Administration (FDA) has granted acceptance to file status of its application for the ... in the disease neurofibromatosis type one (NF1). The FDA’s acceptance of the application ...
(Date:11/12/2019)... ... , ... AI for preventable harm analytics leader Jvion today announced that Jvion ... the Potential of AI”, which provides a “tip of the spear” analysis of the ... enough clients to complete a full KLAS analysis, Jvion was featured as having “by ...
(Date:11/12/2019)... TORONTO (PRWEB) , ... November 12, 2019 , ... ... of a clinical study. With increasing site activation cycle times, extended contract negotiations ... study start-up is an area of clinical operations that’s ripe for improvement. Following ...
Breaking Medicine News(10 mins):
(Date:11/11/2019)... ... November 11, 2019 , ... Oak Street Health , a network of ... new centers in Greensboro and Charlotte, with an additional center in Charlotte under development. ... different model of care that emphasizes quality of care rather than quantity of services. ...
(Date:11/11/2019)... ... November 11, 2019 , ... ... mutual agreement to facilitate the coordination and implementation of joint projects for ... medicinal products. These undertakings will empower biomedical professionals to leverage their roles ...
(Date:11/11/2019)... (PRWEB) , ... November 10, 2019 , ... ... rebranding alongside a redesign of its website , which features over 600 ... from the brand's 35+ year commitment to providing high-quality health and wellness products, ...
Breaking Medicine Technology:
Cached News: